121 results on '"Czul, Frank"'
Search Results
2. Concentrations of 6-Thioguanine Nucleotide Correlate With Trough Levels of Infliximab in Patients With Inflammatory Bowel Disease on Combination Therapy
3. Predictive factors for clinically actionable computed tomography findings in inflammatory bowel disease patients seen in the emergency department with acute gastrointestinal symptoms
4. Quality of Care Provided by Hepatologists to Patients with Cirrhosis at Three Parallel Health Systems
5. Gastric Enterovirus Infection: A Possible Causative Etiology of Gastroparesis
6. Combining Pentoxifylline With Vedolizumab for Crohn’s Disease: Results of a Randomised, Placebo-controlled Pilot Study
7. A Small Percentage of Patients With Hepatitis C Receive Triple Therapy With Boceprevir or Telaprevir
8. Primary Biliary Cirrhosis: Therapeutic Advances
9. Serum Amyloid A as a Surrogate Marker for Mucosal and Histologic Inflammation in Patients with Crohnʼs Disease
10. Continuous-flow Left Ventricular Assist Device, Valvular Disease, and Acquired von Willebrand Syndrome
11. Fr539 COMBINED EFFECT OF PENTOXIFYLLINE WITH VEDOLIZUMAB IN THE MANAGEMENT OF PATIENTS WITH CROHN'S DISEASE
12. 388 HIGHER VISCERAL ADIPOSE TISSUE IS ASSOCIATED WITH LOWER RATES OF STEROID-FREE DEEP AND ENDOSCOPIC REMISSION IN PATIENTS STARTING BIOLOGIC THERAPY FOR INFLAMMATORY BOWEL DISEASES: RESULTS FROM THE CONSTELLATION STUDY
13. Disparities in the Application of Cirrhosis-related Quality of Care Indicators Reflect Site of Care: 1917
14. Inflammatory Cytokine Profile in Crohn’s Disease Nonresponders to Optimal Antitumor Necrosis Factor Therapy
15. Safety, efficacy and tolerability of half-dose sofosbuvir plus simeprevir in treatment of Hepatitis C in patients with end stage renal disease
16. Type 1 autoimmune pancreatitis: case scenario and review of the disease
17. Pancreatitis autoimmune tipo 1: caso y revisión de la enfermedad
18. Characterization of Immune Phenotypes as Predictive Biomarkers for Response to Vedolizumab
19. An uncommon hazard: Pulmonary talcosis as a result of recurrent aspiration of baby powder
20. Signo de la 'piel de leopardo: el uso de endoscopía con magnificación y narrow banding en enfermedad celiaca
21. Persistent Enteritis as the Defining Manifestation of Lupus
22. Noninvasive Markers to Assess Liver Fibrosis
23. Age of Diagnosis is Associated with Disease Presentation and Therapeutic Complications in Patients with Crohnʼs Disease
24. Sa1580 Treatment of Inflammatory Bowel Disease With Vedolizumab for Patients With Coexisting Primary Sclerosing Cholangitis: Report of a Nested Case-Control Study
25. 514 Higher Infliximab Trough Levels Are Associated With a Higher Rate of Perianal Fistula Healing in Patients With Crohn's Disease
26. A Small Bowel With Too Many Exits: An Astonishing Surgical Finding in a Patient With Crohn's Disease
27. Corrigendum to “Safety, efficacy and tolerability of half-dose sofosbuvir plus simeprevir in treatment of Hepatitis C in patients with end stage renal disease” [J Hepatol 2015;63:763–765]
28. Endoscopic management of the complications of pancreatitis
29. Gastric Enterovirus Infection: A Possible Cause of Gastroparesis
30. Tu1035 Characterization of Serious Adverse Events in Hepatitis C Genotype 1 Decompensated Cirrhotic Patients Who Underwent Sofosbuvir and Simeprevir Therapy (Cosmos Regimen)
31. Continuous-flow left ventricular assist devices as a cause of acquired von Willebrand syndrome and GI bleeding
32. Propylthiouracil-Induced Acute Liver Failure: Role of Liver Transplantation
33. Su1955 - Characterization of Immune Phenotypes as Predictive Biomarkers for Response to Vedolizumab
34. Serum Vitamin B12 Level Could Be a Novel Diagnostic Marker to Predict Cirrhosis in Patients With Chronic Liver Disease
35. Serum Certolizumab Pegol Levels and Antibodies to Certolizumab Pegol Are Associated With C-Reactive Protein Levels in Patients With Crohn’s Disease
36. Hepatobiliary Manifestations of Inflammatory Bowel Disease
37. Su1096 Incidence of Inflammatory Bowel Disease Complications in Black Patients: A Cohort Study
38. Primary Biliary Cirrhosis
39. Su2027 Low Albumin and Male Gender Predicts High Ileostomy Outputs in Patients Undergoing Ileostomy Creation
40. Does Abdomino-pelvic CT Done During Emergency Department Visit Affect Management in Patients with Inflammatory Bowel Diseases?: ACG IBD Research Award
41. Diagnosis of Crohnʼs Disease After Age 60 is Associated with Lower Prevalence of Penetrating Phenotype
42. Su1045 Disparities in the Application of Practice Guidelines in Patients With Cirrhosis Reflect Site of Care
43. MELD-Na and MELD Perform Similarly in Predicting Outcomes Post-TIPS
44. Neutrophil-to-Lymphocyte Ratio as a Predictor of Surgical Complications in Inflammatory Bowel Disease
45. Serum Alfa-Feto Protein Level Does Not Predict Micro-Vascular Invasion in Patients Undergoing Orthotopic Liver Transplantation for Hepatocellular Carcinoma
46. M1885 Prevalence of Hepatic Steatosis Based on Ethnicity
47. [Update on chronic pancreatitis: review article].
48. Type 1 autoimmune pancreatitis: case scenario and review of the disease.
49. Image of the Month: A Small Bowel With Too Many Exits: An Astonishing Surgical Finding in a Patient With Crohn's Disease.
50. Safety, efficacy and tolerability of half-dose sofosbuvir plus simeprevir in treatment of Hepatitis C in patients with end stage renal disease.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.